Results 31 to 40 of about 334 (122)
Prognostic factors and genetic markers in thymic epithelial tumors: A narrative review
The aim of this review article is to discuss the different prognostic factors and genetic markers of TET and to point out discrepancies and similarities among the available literature (concerning prognostic factors) and more importantly to demonstrate the genetic pathways that could be the basis of a development of new targeted therapies.
Apostolos C. Agrafiotis +5 more
wiley +1 more source
Here, we report the largest analysis of clinical characteristics of thymomas and outcomes in Latin American patients. Out of 135 patients included in the study, 21.5% (n = 29) concurrently presented myasthenia gravis. Relapse‐free survival rates at five‐years were 58.5% for stage I–II, and 35.4% for stage III. Five‐year overall survival rates were 73.4%
Claudio Martín +29 more
wiley +1 more source
Right VATS Thymomectomy for Large Type AB Thymoma
Radical thymectomy is the traditional surgical management of thymomas. With the advancement of technology, thymomectomy via a minimally invasive approach is gaining popularity, although evidence supporting comparable oncological outcomes remains ...
Joel Dunning (4043288) +2 more
core +1 more source
Summary: Background: Myasthenia gravis (MG) is the most common primary disorder of neuromuscular transmission, but the incidence of MG in China is unknown.
Jingshan Chen +9 more
doaj +1 more source
Inferior Vena Cava and Renal Vein Thrombosis Associated with Thymic Carcinoma
Thymic tumors are rare mediastinal tumors that can present with a wide variety of symptoms. They can cause distant manifestations and are frequently associated with paraneoplastic syndromes. In our case, we describe the evolution of a 68‐year‐old male whose first manifestation was thrombosis of the inferior vena cava and renal veins.
Vlad Teodor Berbecar +6 more
wiley +1 more source
Paraneoplastic Autoimmunity in Thymus Tumors
Autoimmune phenomena are more frequent in thymic epithelial tumors (TET) than in any other human tumor. Mysthenia gravis (MG) is by far the most common autoimmune disease in thymoma patients. MG is characterized by muscle weakness due to autoantibodies against the acetylcholine receptor (AChR), and CD4 +AChR‐specific T cells play a pivotal role for the
Alexander Marx +5 more
wiley +1 more source
Is thymomectomy sufficient for non‐myasthenic early stage thymoma patients? A retrospective, single center experience [PDF]
BackgroundThymic complete resection is considered the standard treatment for all thymic tumors; however, the ideal resection for non‐myasthenic early stage thymic tumors has not yet been determined. We conducted a retrospective study to examine this unique scenario.MethodsWe retrospectively analyzed the data of 118 early stage thymoma patients who ...
Aizemaiti Rusidanmu, Sha Huang, Xiayi Lv
openaire +2 more sources
Standardized definitions and concepts of radicality during minimally invasive thymoma resection [PDF]
Radical thymectomy is the gold standard treatment for thymoma; in particular, completeness of surgical resection of a well-encapsulated thymoma and adequate margins are considered the most important prognostic factors.
Brascia, Debora +17 more
core +1 more source
Myasthenia Crisis Management in the ICU: A Case Report
This study focuses on analyzing the clinical course of myasthenic crisis in post-thymomectomy patients by examining the triggering factors, physiological responses, and the effectiveness of multidisciplinary interventions in stabilization and recovery ...
Dhita Natasha Dwiriyanti +1 more
doaj +1 more source
Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients [PDF]
The World Health Organization (WHO) thymoma histological classification clinical value remains a controversy. In this study, we evaluated its prognostic significance in patients with thymoma treated with radical intent.Six high-volume Italian Thoracic Surgery Institutions collaborated with their own retrospective anonymized datasets.
GUERRERA, Francesco +15 more
openaire +10 more sources

